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Abstract Using a signal sequence trap method and database
search, we identified a series of human cDNAs encoding two
structurally related type I membrane proteins of V25 kDa with
multiple glycosylation motifs. These genes, termed endomucin-
1/-2, are expressed in several human tissues including heart,
kidney, and lung. Exogenously expressed human endomucin-1/-2
proteins were modified into 80^120 kDa glycoproteins, which
were susceptible to O-sialoglycoprotein endopeptidase digestion.
Transient overexpression of endomucin-1/-2 reduced the number
of adhesion plaques and reduced cell attachment to the substrate.
This phenotype was suppressed by laminin or the protein kinase
inhibitor staurosporine. Our findings suggest that human
endomucin-1/-2 negatively regulate cell adhesion to the extra-
cellular matrix. ß 2001 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights reserved.
Key words: Signal sequence trap; Sialomucin;
Vascular endothelium; Anti-adhesion
1. Introduction
Cell^extracellular matrix (ECM) interaction in many types
of cells is mediated by an integrin-based submembranous as-
sembly of proteins termed the focal adhesion complex or ad-
hesion plaque [1]. Formation of focal adhesion complexes is
regulated by cascades of protein^protein interaction and pro-
tein phosphorylation [2]. Several extracellular macromolecules
are known to interfere with cell^ECM interaction; such mol-
ecules include proteoglycans, glycoproteins, and sialoglyco-
proteins [3]. Mucin-like sialoglycoproteins are known to inter-
fere with cadherin-mediated cell^cell interaction as well as
integrin-mediated cell^ECM interaction [4^6]. Steric hin-
drance by their long extracellular domains is postulated as
the mechanism underlying such interference. For instance,
MUC-1/episialin has sialoglycosylated extracellular domains
of 1000^2200 amino acid residues spanning a distance as great
as 200^500 nm.
Several lines of evidence suggest that cell adhesion may also
be regulated in a negative fashion by intracellular mecha-
nisms. For instance, an intracellular protein phosphatase,
PTEN, suppresses integrin-mediated cell spreading and focal
adhesion assembly, probably by antagonizing the focal adhe-
sion kinase FAK [7]. Another intracellular protein, phospho-
inositide 3-kinase, is essential for cell detachment by throm-
bospondin, an anti-adhesive extracellular glycoprotein [8]:
phosphatidylinositol-3,4,5-trisphosphate, a product of the re-
actions catalyzed by phosphoinositide 3-kinase, can rearrange
focal adhesion complexes by interfering with the interaction
between integrin and K-actinin [9].
In a cDNA screen designed to isolate cell surface molecules
involved in mammalian brain development, we identi¢ed a
family of type I membrane proteins termed endomucin-1
and -2. A mouse homolog of endomucin-1 has recently been
reported to be expressed on the vascular endothelial cell sur-
face, although its function has not been elucidated [10]. Here
we report that both human endomucin-1 and -2 interfere with
the assembly of focal adhesion complexes and inhibit cell^
ECM interaction.
2. Materials and methods
2.1. Library construction and signal sequence trap screening
A cDNA expression library was constructed using poly(A) RNA
extracted from mouse brains at gestational day 14 as described pre-
viously [11^14]. In brief, cDNA fragments generated using 5 Wg poly-
(A) RNA and random primers were size-fractionated at 0.4^0.8 kb
and ligated uni-directionally into a yeast expression vector, pSuc2t7-
F1ori, designed to express cDNA-invertase fusion transcripts. This
enzyme cannot be secreted from cells unless the cDNA encodes an
in-frame signal peptide. After transformation of the Saccharomyces
cerevisiae strain YTK12, transformants (4U105 independent clones)
were selected with trisaccharide-based media to isolate clones produc-
ing secretable invertase. cDNAs were ampli¢ed out of the yeast ge-
nomic DNA by PCR (polymerase chain reaction) and sequenced us-
ing a DNA sequencer (ABI373; Perkin Elmer/ABI, Foster City, CA,
USA).
2.2. Isolation of endomucin-2 cDNA
We performed 5P-RACE (rapid ampli¢cation of the 5P-cDNA
end) for endomucin-2 using a human heart-derived cDNA pool (Mar-
athon-Ready, Clontech, Palo Alto, CA, USA), a universal primer
supplied by the manufacturer, and a speci¢c primer, 5P-CCTCA-
GTGCCTATTACTTGAGACTGTGAGG-3P (complementary strand
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of AA426230, bases 13^42). After 35 cycles of PCR, a single 0.7 kb
product was obtained and cloned into pBluescript SK- (Stratagene,
La Jolla, CA, USA), and the nucleotide sequence was determined with
the DNA sequencer.
2.3. RNA blot hybridization
Mouse and human MTN Blots (Clontech) were hybridized with
32P-labeled mouse endomucin-1 cDNA (template: clone AA111512)
and washed with 0.1USSC, 0.1% SDS at 60‡C. Signals were detected
using BAS2000 (Fujix, Tokyo, Japan). The same membranes were
reprobed for human endomucin-1 and -2.
2.4. Construction of expression vectors
To construct vectors expressing human endomucin-1 and -2 cDNAs,
PCR-ampli¢ed human cDNAs were digested with EcoRI plus BamHI
and ligated between the EcoRI and BglII sites of a mammalian ex-
pression plasmid, pCAGGS [15]. A PCR-generated DNA fragment
encoding endomucin-1vSS, which lacks the NH2-terminal signal se-
quence (amino acid residues 2^20), was also ligated into pCAGGS. To
express green £uorescent protein (GFP) fusion proteins, PCR-gener-
ated human endomucin-1/-2 cDNAs lacking the termination codon
were ligated respectively into the HindIII site and between the
XhoI^BamHI sites of pEGFP-N3 (Clontech). To express FLAG-
tagged human endomucin-1/-2, PCR-generated DNA fragments for
endomucin-1vSS or -2vSS were inserted into the HindIII site or be-
tween the EcoRI^BamHI sites of the pFLAG-CMV1 vector (Kodak/
IBI, New Haven, CT, USA). The resulting plasmids express FLAG-
tagged endomucin-1vSS/-2vSS containing the vector-derived, prepro-
trypsin signal sequence at their NH2-termini. We con¢rmed that these
FLAG-tagged proteins were properly targeted to the plasma mem-
brane in HeLa cells by immuno£uorescence staining with the anti-
FLAG antibody M2 (Sigma, St. Louis, MO, USA) (data not shown).
The intactness of each cDNA generated by PCR was con¢rmed by
sequencing.
2.5. Cell culture and transfection
NIH3T3 (mouse ¢broblast), HeLa (derived from human uterine
cancer), and HEK293T (derived from human embryonic kidney) cells
were cultured in Dulbecco’s modi¢ed Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum (FBS) in glass-bottom dishes
(MatTek, Ashland, MA, USA). Plasmids were transfected with a cal-
cium phosphate-based transfection reagent (CellPhect, Amersham
Pharmacia Biotech, Piscataway, NJ, USA) 24^48 h before observation
or protein extraction. For microscopic identi¢cation of cells express-
ing untagged endomucin transgenes, pEGFP-N3 was co-transfected at
a molar ratio of 10:1 (endomucin: GFP marker).
2.6. Protein analyses
HEK293T cells (V107) transfected with the expression vectors for
FLAG epitope-tagged human endomucin-1 or -2 were lysed 24 h after
transfection with 2 ml lysis bu¡er (20 mM Tris^HCl pH 7.4, 0.1%
SDS, 1% Triton X-100, 1 mM PMSF, 1 U/ml aprotinin). The samples
were cleared by centrifugation at 20 000Ug for 30 min, and the super-
natant was incubated at 4‡C for 1 h with 10 Wl agarose beads con-
jugated with anti-FLAG antibodies (Kodak/IBI). The beads were
washed twice with 1 ml lysis bu¡er and resuspended in 50 Wl Tris-
bu¡ered saline (TBS; pH 7.4) with or without 24 Wg O-sialoglycopro-
tein endopeptidase (OSGE; Cederlane Labs, ON, Canada). After in-
cubation at 0‡C or 37‡C for 2 h, the beads were washed twice with
1ml PBS, and the proteins were heat-denatured in a reducing SDS
bu¡er, resolved by SDS^PAGE (10% acrylamide), and transferred
onto a nitrocellulose membrane. The membrane was pretreated with
TBS containing 4% skimmed milk and 0.1% Tween 20 (TBST), in-
cubated with the anti-FLAG antibody, washed three times with
TBST, and incubated with alkaline phosphatase-conjugated anti-
mouse IgG (Promega). After washing with TBST, a chromogenic re-
action was performed with a stabilized substrate for alkaline phos-
phatase (Promega) for 10 min.
2.7. Immuno£uorescence microscopy
Mouse monoclonal antibodies against vinculin (VIN-11^5, Sigma)
and phosphotyrosine (Upstate Biotechnology, Lake Placid, NY,
USA) were used at a concentration of 1 Wg/ml as primary antibodies.
Methods for immuno£uorescence staining and £uorescence microsco-
py were as described previously [16^18].
3. Results
3.1. Isolation of human and mouse endomucin-1 cDNAs
Mouse embryonic cDNAs encoding extracellular proteins
were screened by the signal sequence trap method using S.
cerevisiae as a host [11^14]. This method selects yeast trans-
formants that secrete signal sequence/invertase fusion proteins
and thus are able to utilize trisaccharides as a carbon source.
Fig. 1. Structure of the human and mouse endomucin-1 and -2
cDNAs and their products. A: A schematic representation of the
cDNA fragments analyzed in this study. The open boxes represent
ORFs, with or without preceding in-frame stop codons (*). B:
Alignment of the deduced amino acid sequences of mouse endomu-
cin-1 and human endomucin-1 and -2. A dash and a dot respec-
tively represent an identical amino acid residue and a gap inserted
for maximal alignment. The size (in amino acid residues and molec-
ular weight) and the overall amino acid identity (%) to mouse endo-
mucin-1 are shown after each sequence. The putative signal sequen-
ces and the transmembrane domains are boxed with bold and thin
lines, respectively. Potential N-glycosylation sites are indicated by
triangles. The basic residues in BX7B motifs are indicated by black
squares. Possible sites for glycosaminoglycation are underlined. Po-
tential phosphorylation sites for protein kinase C are indicated by
asterisks. C: Hydrophobicity pro¢les of human endomucin-1 and -2
based on the Kyte^Doolittle (K^D) method. Higher K^D scores in-
dicate higher hydrophobicity. The putative cleavage sites after the
signal sequences (SS) are indicated by arrowheads. Putative N-glyco-
sylation sites (triangles) and the BX7B motifs in the extracellular
domains (BX7B) are also denoted. The local amino acid identities
(in %) are shown between the two pro¢les.
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Two hundred and ninety two clones out of 1.4U105 trans-
formants survived this selection, and the cDNAs from these
clones were sequenced. A database search revealed that these
clones included a number of known genes encoding secreted
or membrane-bound proteins as well as unknown genes en-
coding proteins with putative signal sequences. Among these,
12 independent clones were found to encode a common poly-
peptide. A search of the GenBank database found two match-
ing EST (expressed sequence tag) sequences: one from mouse
(GenBank accession number AA111512) and one from human
(AA085169). We obtained and sequenced the two EST clones
and found that our clone corresponded to the 5P-terminal
portion of the EST clones (Fig. 1A). Each EST clone con-
tained an open reading frame (ORF) of 261 amino acid res-
idues with identical amino acid sequences (Fig. 1B). The cod-
ing regions of the mouse and human ESTs are 99.9%
conserved at the nucleotide sequence level. While this study
was in progress, the mouse endomucin cDNA sequence, which
was virtually identical to the mouse EST clone we analyzed
except for a deletion of 39 bases corresponding to amino acids
T129^S141, was reported [10]. Since all the mouse and human
ESTs in the current database are without this deletion, the
longer cDNA may represent the major mRNA species. In
this report, we refer to the longer mouse cDNA and its human
counterpart as endomucin-1 to distinguish these from the
shorter cDNA species in the mouse [10].
3.2. Isolation of the human endomucin-2 cDNA
A database search with the putative endomucin-1 peptide
sequence detected another human EST clone (AA426230)
which appeared to be truncated at the 5P-end (Fig. 1A). We
performed 5P-RACE based on the sequence of this clone using
a human cDNA pool and obtained a single cDNA of
V700 bp (see Section 2). Sequence analysis of the cDNA
revealed its identity with another EST clone (AA081335; par-
tially sequenced). We obtained this EST clone, and DNA
sequencing revealed that it contained an ORF of 261 amino
acid residues preceded by a consensus for translational initia-
tion [19] and followed by a polyadenylation signal. Since 5P-
RACE gave no clone that extended beyond the 5P-end of
AA081335, this clone probably contains the entire ORF. As
the encoded polypeptide is similar to, but distinct from, the
product of the endomucin-1 cDNA (see below), we named this
cDNA human endomucin-2.
3.3. Structures of endomucin-1 and -2
The mouse endomucin-1 gene and the human endomucin-1
and -2 genes encode polypeptides of 261 amino acid residues
with calculated molecular masses of 27.8, 27.8, and 27.5 kDa,
respectively. Hydrophobicity pro¢les [20] predicted that these
polypeptides contain two major hydrophobic stretches (Fig.
1C). In each polypeptide, the NH2-terminal hydrophobic
stretch of 20 residues is followed by a putative cleavage site
for signal peptidases [21]. The second hydrophobic stretch is
likely to be a transmembrane domain and is £anked by two
hydrophilic regions probably representing extracellular and
cytoplasmic domains. Thus, both endomucin-1 and -2 poly-
peptides are likely to be processed to yield type I membrane
proteins of 241 amino acid residues.
The overall amino acid identity between endomucin-1 and
-2 is 53%. Their similarity is highest in the putative cytoplas-
mic (96%) and transmembrane (86%) domains, and more di-
verged in the signal sequences (40%) and the extracellular
domains (38%) (Fig. 1C). The extracellular domains are rich
in three hydrophilic amino acids, serine, threonine, and pro-
line, which account for 43^45% of the amino acid residues in
this domain. Many of these serine and threonine residues are
potential O-glycosylation sites; by the algorithm of Hansen et
al. [22], 15 sites in endomucin-1 and 14 sites in endomucin-2
are predicted to have a probability of s 0.9 of being O-gly-
cosylated. In addition, each polypeptide has a consensus se-
quence for glycosaminoglycan attachment: one of the hydro-
philic troughs in each extracellular domain contains a heparin
binding motif, BX7B [23]. Unlike the typical mucin core poly-
peptides, however, endomucin-1 and -2 have no MUC-1 re-
peat in their extracellular domains [24]. In the conserved cy-
toplasmic domain, each endomucin contains a sequence which
is conserved in the rhodopsin-like G protein-coupled receptor
superfamily (residues 186^207; searched at http://motif.
genome.ad.jp) and three potential phosphorylation sites for
protein kinase C (http://www.cbs.dtu.dk/databases/Phospho
Base/). Thus, endomucin-1/-2 may function as cell surface
receptors which act to transduce extracellular signals.
Fig. 2. Endomucin mRNAs and proteins. A: Expression of the en-
domucin-1 and -2 genes (abbreviated as Em1 and Em2) in various
human tissues were detected by RNA blot hybridization. Each lane
contained 1 Wg of poly(A) RNA extracted from the indicated tis-
sues. B: FLAG-endomucin-1 and FLAG-endomucin-2 transiently
expressed in HEK293T cells were immunoprecipitated with anti-
FLAG antibodies, and then incubated for 2 h either on ice (lane 1)
or at 37‡C (lanes 2 and 3) without (lanes 1 and 2) or with OSGE
(lane 3). The tagged proteins were detected by immunoblot assay
using anti-FLAG antibodies. Note that the majority of the tagged
endomucin-1 and -2 were post-translationally modi¢ed and ran at
an apparent size of 80^110 and 90^120 kDa, respectively, and were
completely degraded by OSGE treatment. A minor band in the
FLAG-endomucin-2 blot (V55 kDa) that showed partial suscepti-
bility to OSGE may represent an O-sialoglycosylation intermediate.
The other minor bands of 6 30 kDa were resistant to OSGE, sug-
gesting that they may represent unmodi¢ed core proteins. Their re-
sistance to OSGE argues against non-selective degradation of the
major bands by contaminating proteases.
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3.4. Expression of the endogenous endomucin-1 and -2 genes
Expression patterns of endomucin-1 and -2 in human tissues
were assessed by RNA blot hybridization (Fig. 2A,B). Both
genes are expressed in many organs, and the signals are espe-
cially strong in the heart, kidney, and lung. The endomucin-2
probe consistently yielded stronger signals than the endomu-
cin-1 probe under similar experimental conditions, suggesting
higher steady-state expression of the endomucin-2 gene in hu-
man tissues. Both probes detected two mRNA species; the
lengths of the EST clones (V1.5 kb without poly A tail)
are comparable to the shorter transcripts (V1.8 kb).
Although the identities of the longer transcripts (V4.4 kb)
are currently unknown, the concordant expression patterns
of the two transcripts suggest that they may represent alter-
natively processed mRNA species transcribed from the same
gene. Mouse tissue blots probed with the human endomucin-1
cDNA showed abundant expression of theV1.8 kb transcript
in the heart, kidney, and lung (data not shown), which is
consistent with the data in a previous report [10]. Interest-
ingly, however, the human endomucin-2 probe detected no
signals on the mouse RNA blots (data not shown). These
results, together with the fact that no endomucin-1-related
genes were isolated in our initial screening, suggest that the
mouse genome may not contain the orthologue of the human
endomucin-2 gene, or even if it does, the gene may be highly
diverged or expressed at only very low levels.
3.5. Subcellular localization and O-sialoglycosylation of the
endomucin-1 and -2 proteins
Subcellular localization of human endomucin-1 and -2 was
assessed by expressing these proteins tagged with the Aequo-
rea GFP at their carboxy-termini. When transiently expressed
in HEK293T and HeLa cells, the endomucin-1^GFP and en-
domucin-2^GFP consistently localized to the plasma mem-
brane and less abundantly to Golgi-like perinuclear stacks
(Fig. 3E^G,J and data not shown). To analyze post-transla-
tional modi¢cation, endomucin-1 and -2 tagged with the
FLAG epitope (see Section 2) were expressed in HEK293T
cells. Using immunoprecipitation and immunoblot detection
with anti-FLAG antibodies, FLAG-endomucin-1 appeared as
two bands, a major broad band ranging from 80 to 100 kDa
and a minor band around 30 kDa. FLAG-endomucin-2 ap-
peared as three bands, a major broad band ranging from 90 to
120 kDa, a minor band around 60 kDa, and a second minor
band a little under 30 kDa (Fig. 2B, lanes 1). FLAG-endo-
mucin products were not detected in the tissue culture media
48 h after transfection (data not shown), suggesting that se-
cretion or shedding of the extracellular domain is unlikely, at
least in this system.
Since extracellular domains of endomucin-1 and -2 have
numerous potential O-sialoglycosylation sites, we tested the
possibility of O-sialoglycosylation by treating the immunopre-
cipitated proteins with Mannheimia O-sialoglycoprotein endo-
peptidase which speci¢cally cleaves O-sialoglycosylated pro-
teins [25]. Both of the major high molecular weight FLAG-
endomucin bands completely disappeared after OSGE-treat-
ment (Fig. 2B, lanes 3), demonstrating susceptibility of these
proteins to OSGE due to O-sialoglycosylation. Taken togeth-
er, these results indicate that endomucin-1 and -2 polypeptides
are O-sialoglycosylated, targeted to the plasma membrane,
and retained there as type-I membrane proteins with apparent
molecular weights of 80^100 and 90^120 kDa, respectively.
3.6. Overexpression of endomucin-1 or -2 promotes cell
detachment
To study the biological activities of the endomucins, we co-
transfected a vector expressing the untagged human endomu-
cin-1 or -2 and a GFP-expression vector into HEK293T cells
and observed the morphology of the transfected cells. Inter-
estingly, 24^48 h after transfection the majority of the trans-
fectants had become round-shaped and some of them were
detached from the glass surface (Fig. 3B,C). The GFP-fused
endomucins also induced similar morphological changes in
HEK293T cells (Fig. 3E^G,J). In contrast, endomucin-1vSS,
lacking the signal sequence, failed to show such activity (Fig.
3D and data not shown), suggesting that membrane localiza-
tion is essential for this activity. We also tested the importance
of the putative hyaluronate binding motifs (BX7B) in the
extracellular domain of endomucin-1 by replacing one of the
Fig. 3. Biological activity and subcellular localization of endomucin-
1 and -2 expressed in the human cell line HEK293T. Cells were co-
transfected with a GFP-expression vector (transfection marker) plus
the control vector (A), or the vector expressing endomucin-1 (B),
endomucin-2 (C), or endomucin-1vSS (D). Most of the endomucin-
1/-2 transfectants with green £uorescence (shown as white signals)
were round-shaped at 24 h after transfection (B and C). In contrast,
the control vector and the vector expressing endomucin-1 without a
signal sequence (vSS) showed no such activity (A and D). Endomu-
cin-1^GFP (E) and endomucin-2^GFP (F) fusion proteins were con-
centrated on the plasma membrane and in Golgi-like structures, and
exhibited similar rounding inducing activity as the untagged pro-
teins. Higher magni¢cation of endomucin-1^GFP (G^I) and endo-
mucin-2^GFP expressing cells (J^L) at 48 h after transfection. Some
cells are detached from the uncoated glass surface and out of focus
(G and J). Coating of the glass surface with 1 Wg/cm2 laminin (H
and K) or addition of 10 nM staurosporine to the medium (I and
L) suppressed the morphological changes in spite of the persistent
membrane localization of endomucin^GFPs. Bar: 20 Wm in A^F, 40
Wm in G^L.
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two basic residues in these motifs with alanine (i.e. K128A
and R136A). These mutants retained the rounding/detach-
ment inducing activity (data not shown), suggesting that these
motifs have little or no role in this particular activity.
3.7. Overexpression of endomucin-1 interferes with the
assembly of focal adhesion complex
To test the possible functional interaction between endomu-
cins and the focal adhesion complex, we expressed endomu-
cin-1^GFP in NIH3T3 cells, whose adhesion mechanism has
been well studied. Unlike HEK293 and HeLa cells, NIH3T3
cells did not show any obvious rounding or detachment after
endomucin-1^GFP expression (Fig. 4A and data not shown).
Interestingly, however, the number of adhesion plaques la-
beled with antibodies against vinculin or phosphotyrosine
were markedly reduced (Fig. 4B,C) in comparison with the
cells transfected with the control GFP-expression vector
(Fig. 4D). Moreover, untransfected cells with numerous adhe-
sion plaques (Fig. 4B,C; cells without red pseudocolor) were
frequently seen beneath the transfectants, suggesting a loss of
tight contact between the endomucin expressing cells and the
glass surface. These observations indicate that overexpression
of endomucin-1 interfered with assembly of focal adhesion
complexes in ¢broblasts, causing partial detachment of the
cells from the substrate.
3.8. Anti-adhesive activity of endomucin-1/-2 is suppressed by
ECM proteins and staurosporine
To ¢nd clues to the mechanism by which endomucin a¡ects
focal adhesion complexes and cell attachment, we tested the
e¡ects of culture substrate (extracellular signals) and protein
kinase inhibitors (intracellular signals) on the anti-adhesive
activity of endomucins. When HEK293T cells expressing en-
domucin-1^GFP or endomucin-2^GFP were plated on a lam-
inin-coated glass surface, they remained attached with a £at
morphology (Fig. 3H,K). Similar e¡ects were observed with
other ECM proteins such as collagen-I and ¢bronectin (data
not shown). We also found that a protein kinase inhibitor,
staurosporine, promoted attachment of these endomucin ex-
pressing cells to the uncoated glass surface (Fig. 3I,L). Stau-
rosporine is known to promote cell spreading by modifying
focal adhesion components [26]. Although increased cytoplas-
mic accumulation of the endomucin^GFP fusion proteins was
seen, a signi¢cant proportion of the endomucin^GFP signal
was found on the plasma membrane. Thus, the anti-adhesive
activities of endomucin-1 and -2 are reversible by ECM pro-
teins or a protein kinase inhibitor that are known to promote
cell adhesion. These ¢ndings suggest that the rounding and
detachment of the cells overexpressing endomucin-1/-2 re£ect
an interference with the cell adhesion machinery rather than
non-speci¢c cytotoxicity by protein overproduction.
4. Discussion
We have isolated and characterized a series of mammalian
cDNAs encoding structurally related membrane-bound O-sia-
loglycoproteins, endomucin-1 and -2. We also showed that
they are widely expressed in human tissues and have the po-
tential to interfere with the assembly of focal adhesion com-
plexes and cell attachment. Among the mucin-like sialoglyco-
proteins characterized to date, endomucin-1/-2 are unique in
their short extracellular domains (170 amino acid residues)
and the lack of MUC-1 repeats. Thus, whether endomucin-
1/-2 exert their anti-adhesive activity through a mechanism
distinct from that used by other mucin-like proteins is an
important question that remains to be addressed in future
studies.
Our ¢nding that ECM proteins or staurosporine can sup-
press the anti-adhesive activity of endomucin-1/-2 suggests the
involvement of some intracellular signaling events, rather than
mere physical interference of cell^ECM interaction, in this
activity. Staurosporine is known to promote integrin-mediated
cell adhesion by stimulating tyrosine phosphorylation of Src
and tensin in the focal adhesion complex [26]. Additionally,
capping of sialomucins, CD34 and CD43, is known to acti-
vate Syk and Lyn tyrosine kinases in hematopoietic cells [27].
Thus, endomucin-1/-2 might also alter cell behavior through
protein kinases that regulate the assembly of focal adhesion
complexes. Identi¢cation of cellular proteins interacting with
the highly conserved cytoplasmic domains of endomucin-1
and -2 may provide clues for the elucidation of such intra-
cellular events.
We attempted to raise speci¢c antibodies against endomu-
cin-1 and -2 using six distinct synthetic oligopeptides as anti-
gens. Unfortunately, however, none of the sera recognized
mature proteins in mouse tissues or recombinant proteins ex-
pressed in cultured cells. This is probably because the endo-
mucin core peptides are highly deformed and/or masked by
Fig. 4. Endomucin-1 overexpression interferes with assembly of fo-
cal adhesion complex in ¢broblasts. A: NIH3T3 cells 24 h after
transfection of endomucin-1^GFP exhibited minimal morphological
changes except a few rounded cells. Subcellular localization of the
fusion protein was comparable to that observed in human epithelial
cell lines. B^D: E¡ects of endomucin-1 expression on focal adhesion
assembly. Pseudocolor images of ¢xed transfectants expressing endo-
mucin-1^GFP (B, C) or GFP alone (D) with immunostaining either
for vinculin (red) or phosphotyrosine (green). Note that untrans-
fected cells with numerous focal adhesion complexes are underlying
the transfected cells, and that these transfected cells have poorly or-
ganized focal adhesion complexes (B and C). Bar: 20 Wm in A, 120
Wm in B^D.
FEBS 24943 12-6-01 Cyaan Magenta Geel Zwart
M. Kinoshita et al./FEBS Letters 499 (2001) 121^126 125
the sialoglycoside moieties. This is also consistent with pre-
vious ¢ndings that antibodies against mouse endomucin were
less reactive toward the deglycosylated protein [10].
Mouse endomucin was found to be expressed on vascular
endothelial cells [10], and this led to the proposal that endo-
mucin may function as a negative regulator for endothelial
attachment to the basement membrane or cell^cell adhesion
among endothelial cells. Another possible role for endomucins
is negative regulation of leukocyte adhesion onto the vascular
endothelia. In support of this hypothesis, mouse endomucin is
not expressed on the luminal surface of high endothelial ven-
ule (HEV) [10], a specialized site for leukocyte attachment in
lymphoid organs. Rather, another sialoglycoprotein, CD34,
expressed on HEV serves as a ligand for a leukocyte adhesion
molecule, L-selectin [28]. This raises a third possibility, that
endomucins might function as ligands, receptors, or co-recep-
tors for cell adhesion and/or cell recognition systems. Interest-
ingly, CD43 is known to be di¡erentially sialoglycosylated to
yield 130 kDa and 115 kDa molecules with di¡erent anti-ad-
hesive activity [29]. Likewise, the epitope-tagged endomucin-1
and -2 expressed in cultured cells (80^100 kDa and 90^120
kDa, respectively) as well as the mouse endogenous endomu-
cin of 70^90 kDa [10] may represent molecules with variable
O-silaloglycosylation patterns and distinct activities. It may
therefore be important to focus on the biologically relevant
glycoforms in future functional studies.
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